Antipsychotic-induced suppression of locomotion in juvenile, adolescent and adult rats

European Journal of Pharmacology

Volumn 578, Issue 2-3, 2008, Pages 216-221

  Wiley, Jenny L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Adolescence; Clozapine; Haloperidol; Locomotion; Sex differences; Tolerance

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG TOLERANCE; EXPERIMENTAL STUDY; FEMALE; JUVENILE; LOCOMOTION; MALE; NONHUMAN; POSTNATAL CARE; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

AGE FACTORS; AGING; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FEMALE; HALOPERIDOL; MALE; MOTOR ACTIVITY; RATS; RATS, LONG-EVANS; TIME FACTORS;

EID: 37349114792     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.09.010     Document Type: Article

References (23)

1. Campbell A., and Baldessarini R.J. Effects of maturation and aging on behavioral responses to haloperidol in the rat. Psychopharmacology (Berl) 73 (1981) 219-222
2. Campbell A., Baldessarini R.J., and Teicher M.H. Decreasing sensitivity to neuroleptic agents in developing rats; evidence for a pharmacodynamic factor. Psychopharmacology (Berl) 94 (1988) 46-51
3. Carey R.J., DePalma G., and Damianopoulos E. Acute and chronic cocaine behavioral effects in novel versus familiar environments: open-field familiarity differentiates cocaine locomotor stimulant effects from cocaine emotional behavioral effects. Behav. Brain Res. 158 (2005) 321-330
4. Coyle S., Napier T.C., and Breese G.R. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures. Brain Res. 355 (1985) 27-38
5. Cuomo V., Cagiano R., Coen E., Mocchetti I., Cattabeni F., and Racagni G. Enduring behavioural and biochemical effects in the adult rat after prolonged postnatal administration of haloperidol. Psychopharmacology (Berl) 74 (1981) 166-169
6. Cuomo V., Cagiano R., Mocchetti I., Coen E., Cattabeni F., and Racagni G. Behavioural and biochemical effects in the adult rat after prolonged postnatal administration of clozapine. Psychopharmacology (Berl) 81 (1983) 239-243
7. Cuomo V., Cagiano R., Renna G., Serinelli A., Brunello N., and Racagni G. Comparative evaluation of the behavioural consequences of prenatal and early postnatal exposure to haloperidol in rats. Neurobehav. Toxicol. Teratol. 7 (1985) 489-492
8. Gramling S.E., and Fowler S.C. Effects of neuroleptics on rate and duration of operant versus reflexive licking in rats. Pharmacol. Biochem. Behav. 22 (1985) 541-545
9. Leussis M.P., and Bolivar V.J. Habituation in rodents: a review of behavior, neurobiology, and genetics. Neurosci. Biobehav. Rev. 30 (2006) 1045-1064
10. McQuade R.D., Duffy R.A., Coffin V.L., and Barnett A. In vivo binding to dopamine receptors: a correlate of potential antipsychotic activity. Eur. J. Pharmacol. 215 (1992) 29-34
11. Moody C.A., Robinson S.R., Spear L.P., and Smotherman W.P. Fetal behavior and the dopamine system: activity effects of D1 and D2 receptor manipulations. Pharmacol. Biochem. Behav. 44 (1993) 843-850
12. Napier T.C., Coyle S., and Breese G.R. Ontogeny of striatal unit activity and effects of single or repeated haloperidol administration in rats. Brain Res. 333 (1985) 35-44
13. National Research Council. Guide for the Care and Use of Laboratory Animals (1996), National Academy Press, Washington, D.C.
14. Renner M.J., Bennett A.J., and White J.C. Age and sex as factors influencing spontaneous exploration and object investigation by preadult rats (Rattus norvegicus). J. Comp. Psychol. 106 (1992) 217-227
15. Schotte A., Janssen P.F., Gommeren W., Luyten W.H., Van Gompel P., Lesage A.S., De Loore K., and Leysen J.E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124 (1996) 57-73
16. Shalaby I.A., and Spear L.P. Chronic administration of haloperidol during development: later psychopharmacological responses to apomorphine and arecoline. Pharmacol. Biochem. Behav. 13 (1980) 685-690
17. Simon V.M., Parra A., Minarro J., Arenas M.C., Vinader-Caerols C., and Aguilar M.A. Predicting how equipotent doses of chlorpromazine, haloperidol, sulpiride, raclopride and clozapine reduce locomotor activity in mice. Eur. Neuropsychopharmacol. 10 (2000) 159-164
18. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 24 (2000) 417-463
19. Spear L.P., Shalaby I.A., and Brick J. Chronic administration of haloperidol during development: behavioral and psychopharmacological effects. Psychopharmacology (Berl) 70 (1980) 47-58
20. Tarazi F.I., and Baldessarini R.J. Comparative postnatal development of dopamine D(1), D(2) and D(4) receptors in rat forebrain. Int. J. Dev. Neurosci. 18 (2000) 29-37
21. Varvel S.A., Vann R.E., Wise L.E., Philibin S.D., and Porter J.H. Effects of antipsychotic drugs on operant responding after acute and repeated administration. Psychopharmacology (Berl) 160 (2002) 182-191
22. Weihmuller F.B., and Bruno J.P. Age-dependent plasticity in the dopaminergic control of sensorimotor development. Behav. Brain Res. 35 (1989) 95-109
23. Wiley J.L., and Martin B.R. Cannabinoid pharmacological properties common to other centrally acting drugs. Eur. J. Pharmacol. 471 (2003) 185-193